Skip to main content
Clinical Trials/JPRN-UMIN000013590
JPRN-UMIN000013590Completed未知

The evaluation of the efficacy and safety of Hainosankyuto on purulence in patients with lymphedema - The effect of Hainosankyuto on purulence in patients with lymphedema

Hokkaido University School of Medicine0 sites20 target enrollmentStarted: May 7, 2014Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 75years-old (—)
Sex
Female

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1)Patients with aldosteronism, myopathy and hypokalemia 2)Patients who were prescribed Kampo medicine within 4 weeks before entry 3)Patients who were prescribed an adrenocortical hormonic agent or an anti-allergic agent 4)Patients with serious complications (liver, kidney, heart, blood, or metabolic disorders) 5)Patients with recurrent or metastasized cancer 6)Pregnant patients, breast-feeding patients or patients hoping to become pregnant 7)Patients considered inappropriate by the study investigator

Investigators

Sponsor
Hokkaido University School of Medicine

Similar Trials